Evidence map›Paper›PMID 40862053›Full record

ArticleResearch (Washington, D.C.)2025

Ab Initio Accuracy Neural Network Potential for Drug-Like Molecules.

Manyi Yang, Duo Zhang, Xinyan Wang, BoWen Li, Linfeng Zhang, Weinan E, Tong Zhu, Han Wang

Abstract read
In one paragraph

Article in Research (Washington, D.C.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Manyi YangThe Institute of Green Chemistry and Engineering, Nanjing University, Suzhou, Jiangsu 215163, China.ORCID https://orcid.org/0000-0001-9791-093X
Duo ZhangAI for Science Institute, Beijing 100080, China.
Xinyan WangDP Technology, Beijing 100080, China.
BoWen LiShanghai Engineering Research Center of Molecular Therapeutics & New Drug Development, School of Chemistry and Molecular Engineering, East China Normal University, Shanghai 200062, China.
Linfeng ZhangAI for Science Institute, Beijing 100080, China.
Weinan EAI for Science Institute, Beijing 100080, China.
Tong ZhuShanghai Engineering Research Center of Molecular Therapeutics & New Drug Development, School of Chemistry and Molecular Engineering, East China Normal University, Shanghai 200062, China.ORCID https://orcid.org/0000-0001-7472-3736
Han WangNational Key Laboratory of Computational Physics, Institute of Applied Physics and Computational Mathematics, Beijing 100088, China.ORCID https://orcid.org/0000-0001-5623-1148

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The advent of machine learning (ML) in computational chemistry heralds a transformative approach to one of the quintessential challenges in computer-aided drug design (CADD): the accurate and cost-effective calculation of atomic interactions. By leveraging a neural network (NN) potential, we address this balance and push the boundaries of the NN potential's representational capacity. Our work details the development of a robust general-purpose NN potential, architected on the framework of DPA-2, a deep learning potential with attention, which demonstrates remarkable fidelity in replicating the interatomic potential energy surface for drug-like molecules comprising 8 critical chemical elements: H, C, N, O, F, S, Cl, and P. We employed state-of-the-art molecular dynamic (MD) techniques, including temperature acceleration and enhanced sampling, to construct a comprehensive dataset to ensure exhaustive coverage of relevant configurational spaces. Our rigorous testing protocols, including torsion scanning, structure relaxation, and high-temperature MD simulations across various organic molecules, have culminated in an NN model that achieves chemical precision commensurate with the highly regarded density functional theory model while substantially outstripping the accuracy of prevalent semi-empirical methods. This study presents a leap forward in the predictive modeling of molecular interactions, offering extensive applications in drug development and beyond.

Identifiers

PMID40862053
PMCPMC12377527

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.